| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The FASEB Journal, Vol 9, 843-851, Copyright © 1995 by The Federation of American Societies for Experimental Biology
REVIEWS |
T Finkel and SE Epstein
Cardiology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892-1650, USA.
Highly efficient methods that are now available allow for the genetic modification of cells that compose the vessel wall. The application of these gene transfer systems are already providing information that has enhanced our understanding of a variety of cellular processes relating to vascular biology. Recent experimental results using this technology also hold promise for more powerful therapeutic options in the treatment of vascular disease. This review discusses the most commonly used methods of gene transfer and details some current applications of these methodologies in animal models of vascular disease.
This article has been cited by other articles:
|
|
 |
|
  R. G. Fahmy and L. M. Khachigian Locked nucleic acid modified DNA enzymes targeting early growth response-1 inhibit human vascular smooth muscle cell growth Nucleic Acids Res., April 23, 2004; 32(7): 2281 - 2285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Pels, C. Deiner, S. E Coupland, M. Noutsias, A. P Sutter, H.-P. Schultheiss, S. Yla-Herttuala, and P. L Schwimmbeck Effect of adventitial VEGF165 gene transfer on vascular thickening after coronary artery balloon injury Cardiovasc Res, December 1, 2003; 60(3): 664 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J M Edelberg, D T Huang, M E Josephson, and R D Rosenberg Molecular enhancement of porcine cardiac chronotropy Heart, November 1, 2001; 86(5): 559 - 562. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Christ, J. Rehman, N. Day, L. Salkoff, M. Valcic, A. Melman, and J. Geliebter Intracorporal injection of hSlo cDNA in rats produces physiologically relevant alterations in penile function Am J Physiol Heart Circ Physiol, August 1, 1998; 275(2): H600 - H608. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Braun-Dullaeus, M. J. Mann, and V. J. Dzau Cell Cycle Progression : New Therapeutic Target for Vascular Proliferative Disease Circulation, July 7, 1998; 98(1): 82 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Lu, H. Yang, and M. K. Raizada Attenuation of ANG II actions by adenovirus delivery of AT1 receptor antisense in neurons and SMC Am J Physiol Heart Circ Physiol, February 1, 1998; 274(2): H719 - H727. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Pepper Manipulating Angiogenesis: From Basic Science to the Bedside Arterioscler. Thromb. Vasc. Biol., April 1, 1997; 17(4): 605 - 619. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. Onoda, S. Ono, K. Ogihara, T. Shiota, S. Asari, T. Ohmoto, Y. Ninomiya, and W. I. Rosenblum Role of Extracellular Matrix in Experimental Vasospasm: Inhibitory Effect of Antisense Oligonucleotide on Collagen Induction Stroke, November 1, 1996; 27(11): 2102 - 2109. [Abstract] [Full Text]
|
|
|
|
|
|
D. D. Heistad and F. M. Faraci Gene Therapy for Cerebral Vascular Disease Stroke, September 1, 1996; 27(9): 1688 - 1693. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
